First Horizon National (NYSE:FHN) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.38 by 5.26 percent. This is a 13.04 percent decrease over earnings of $0.46 per share from the same period last year.
Phathom’s Vonoprazan Non-Inferior To Proton Pump Inhibitor For Esophagitis Inflammation
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) has announced data from the PHALCON-EE Phase 3 trial evaluating vonoprazan versus lansoprazole for erosive esophagitis (EE). …